Congress asks FDA if “actual use” is factor in medical app regulation | mobihealthnews:
". . . The letter also asks whether the FDA will consider the “actual use” of a mobile medical app in addition to the “intended use” when making its determination about whether an app needs to go through the 510(K) process. Finally, the letter closes with a series of questions related to the final guidance document and the committee wants answers by March 15th."
'via Blog this'
Read the Letter Sent to FDA Commissioner Margaret Hamburg (pdf)
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Thursday, March 7, 2013
FDA Asked About Mobile Apps and the FDA 510K Process
Subscribe to:
Post Comments (Atom)
From SkillsPlus International Inc.
- Popular cGMP Online Training Courses Updated
- As Supply Chain Partners Ramp Up For November DSCSA Deadline, US FDA Gives Them Another Year - Pink Sheet
- California Designated Representative 3PL Training Course
- DRUG FRAUD ALERT: DISTRIBUTOR/CUSTOMER PRODUCT ORDERING SCHEME
- Drug Products, Including Biological Products, that Contain Nanomaterials - Final Guidance Document
No comments:
Post a Comment